Advertisement
Original Article| Volume 62, ISSUE 4, P327-331, August 15, 2007

Download started.

Ok

Novel 5-HTTLPR Allele Associates with Higher Serotonin Transporter Binding in Putamen: A [11C] DASB Positron Emission Tomography Study

      Background

      The serotonin transporter (5-HTT)-linked polymorphic region (5-HTTLPR) has two frequent alleles, designated long (L), and short (S). The S allele is associated with lower levels of 5-HTT mRNA and lower 5-HTT expression in human cell lines. A functional single nucleotide variant was detected within L, designated LA and LG. Only LA is associated with high levels of in vitro 5-HTT expression, whereas LG is low expressing and more similar to S. We examined the possible influence of the long (A/G) variant on 5-HTT density in the living human brain using 3-(11)C-amino-4-(2-dimethylaminomethylphenyl-sulfanyl) benzonitrile ([11C]DASB) positron emission tomography.

      Methods

      The 5-HTT binding potential (5-HTT BP), an index of 5-HTT density, was found in 43 healthy subjects genotyped for 5-HTTLPR long (A/G), and in an ethnically homogenous subsample of 30 Caucasian-Canadians.

      Results

      The LA/LA was associated with higher 5-HTT BP in putamen (p = .026, not corrected). This association became stronger in the Caucasian subsample (p = .004) and was significant even after correcting for multiple comparisons.

      Conclusions

      The 5-HTTLPR long (A/G) polymorphism influences 5-HTT density leading to higher putamen 5-HTT BP in healthy LA/LA carriers of Caucasian ancestry. This finding extends the role of this polymorphism from in vitro reports of higher 5-HTT expression with the LA/LA genotype into in vivo brains of healthy human subjects.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anguelova M.
        • Benkelfat C.
        • Turecki G.
        A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I.
        Mol Psychiatry. 2003; 8: 574-591
        • Arango V.
        • Ernsberger P.
        • Marzuk P.M.
        • Chen J.S.
        • Tierney H.
        • Stanley M.
        • et al.
        Autoradiographic demonstration of increased serotonin-5HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims.
        Arch Gen Psychiatry. 1990; 47: 1038-1047
        • Bondy B.
        • Buettner A.
        • Zill P.
        Genetics of suicide.
        Mol Psychiatry. 2006; 11: 336-351
        • Burger C.
        • Buck A.
        Requirements and implementation of a flexible kinetic modelling tool.
        J Nucl Med. 1997; 38: 1818-1823
        • Caspi A.
        • Sudgen K.
        • Moffitt T.E.
        • Taylor A.
        • Craig I.W.
        • Harrington H.L.
        Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene.
        Science. 2003; 301: 386-389
        • Cook E.H.
        • Courchesne R.
        • Lord C.
        • Cox N.J.
        • Yan S.
        • Lincoln A.
        • et al.
        Evidence of linkage between the serotonin transporter and autistic disorder.
        Mol Psychiatry. 1997; 2: 247-250
        • De Luca V.
        • Tharmalingam S.
        • King N.
        • Strauss J.
        • Bulgin N.
        • Kennedy J.L.
        Association study of a novel functional polymorphism of the serotonin transporter gene in bipolar disorder and suicidal behavior.
        Psychopharmacology (Berl.). 2005; 182: 128-131
        • De Luca V.
        • Zai G.
        • Tharmalingam S.
        • de Bartolomeis A.
        • Wong G.
        • Kennedy J.L.
        Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behavior in schizophrenia.
        Eur Neuropsychopharmacol. 2006; 6: 268-271
        • Drevets W.C.
        • Price J.L.
        • Simpson Jr, J.R.
        • Todd R.D.
        • Reich T.
        • Vannier M.
        • et al.
        Subgenual prefrontal cortex abnormalities in mood disorders.
        Nature. 1997; 386: 824-827
        • First M.B.
        • Gibbon M.
        • Spitzer R.L.
        • Williams J.B.W.
        Structured Clinical Interview for DSM-IV Nonpatient Version. Biometrics Department, New York State Psychiatric Institute, New York, NY1996
        • Ginovart N.
        • Wilson A.A.
        • Meyer J.H.
        • Hussey D.
        • Houle S.
        Positron emission tomography quantification of [11C] DASB binding to the human serotonin transporter: Modeling strategies.
        J Cereb Blood Flow Metab. 2001; 21: 1342-1353
        • Haberstick B.C.
        • Smolen A.
        • Hewitt J.K.
        Family-based association test of the 5HTTLPR and aggressive behavior in a general population sample of children.
        Biol Psychiatry. 2006; 59: 836-843
        • Hasler G.
        • Kazuba D.
        • Murphy D.L.
        Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism.
        Am J Med Genet B Neuropsychiatr Genet. 2006; 141: 403-408
        • Heils A.
        • Teufel A.
        • Petri S.
        • Seemann M.
        • Bengel D.
        • Balling U.
        • et al.
        Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene.
        J Neural Transm Gen Sect. 1995; 102: 247-254
        • Heils A.
        • Teufel A.
        • Petri S.
        • Stober G.
        • Riederer P.
        • Bengel D.
        • Lesch K.P.
        Allelic variation of human serotonin transporter gene expression.
        J Neurochem. 1996; 66: 2621-2624
        • Heinz A.
        • Braus D.F.
        • Smolka M.N.
        • Wrase J.
        • Puls I.
        • Hermann D.
        • et al.
        Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter.
        Nat Neurosci. 2005; 8: 20-21
        • Heinz A.
        • Jones D.W.
        • Mazzanti C.
        • Goldman D.
        • Ragan P.
        • Hommer D.
        • et al.
        A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.
        Biol Psychiatry. 2000; 47: 643-649
        • Hoefgen B.
        • Schulze T.G.
        • Ohlraun S.
        • von Widdern O.
        • Hofels S.
        • Gross M.
        The power of sample size and homogenous sampling: Association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder.
        Biol Psychiatry. 2005; 57: 247-251
        • Houle S.
        • Ginovart N.
        • Hussey D.
        • Meyer J.H.
        • Wilson A.A.
        Imaging the serotonin transporter with positron emission tomography: Initial human studies with [11C] DAPP and [11C] DASB.
        Eur J Nucl Med. 2000; 27: 1719-1722
        • Hrdina P.D.
        • Demeter E.
        • Vu T.B.
        • Sotonyi B.
        • Palkovits M.
        5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: Increase in 5-HT2 sites in cortex and amygdale.
        Brain Res. 1993; 614: 37-44
        • Hu X.
        • Lipsky R.H.
        • Zhu G.
        • Akhtar L.A.
        • Taubman J.
        • Greenberg B.D.
        Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.
        Am J Hum Gen. 2006; 78: 815-826
        • Hu X.
        • Oroszi G.
        • Chun J.
        • Smith T.L.
        • Goldman D.
        • Schuckit M.A.
        An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk.
        Alcohol Clin Exp Res. 2005; 29: 8-16
        • Ichise M.
        • Liow J.S.
        • Lu J.Q.
        • Takano A.
        • Model K.
        • Toyama H.
        • et al.
        Linearized reference tissue parametric imaging methods: Application to [11C] DASB positron emission tomography studies of the serotonin transporter in human brain.
        J Cereb Blood Flow Metab. 2003; 23: 1096-1112
        • Ichise M.
        • Meyer J.H.
        • Yonekura Y.
        An introduction to PET and SPECT neuroreceptor quantification models.
        J Nucl Med. 2001; 42: 755-763
        • Kish S.J.
        • Furukawa Y.
        • Chang L.J.
        • Tong J.
        • Ginovart N.
        • Wilson A.
        • et al.
        Regional distribution of serotonin transporter protein in postmortem human brain: Is the cerebellum a SERT-free brain region?.
        Nucl Med Biol. 2005; 32: 123-128
        • Kraft J.B.
        • Slager S.L.
        • McGrath P.J.
        • Hamilton S.P.
        Sequence analysis of the serotonin transporter and associations with antidepressant response.
        Biol Psychiatry. 2005; 58: 374-381
        • Lahiri D.K.
        • Nurnberger J.I.
        A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies.
        Nucleic Acids Res. 1991; 19: 5444
        • Lesch K.P.
        • Bengel D.
        • Heils A.
        • Sabol S.Z.
        • Greenberg B.D.
        • Petri S.
        • et al.
        Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.
        Science. 1996; 274: 1527-1531
        • Lim J.E.
        • Papp A.
        • Pinsonneault J.
        • Sadee W.
        • Saffen D.
        Allelic expression of serotonin transporter (SERT) mRNA in human pons: Lack of correlation with the polymorphism SERTLPR.
        Mol Psychiatry. 2006; 11: 649-662
        • Little K.Y.
        • McLaughlin D.P.
        • Zhang L.
        • Livermore C.S.
        • Dalack G.W.
        • McFinton P.R.
        • et al.
        Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels.
        Am J Psychiatry. 1998; 155: 207-213
        • Logan J.
        • Fowler J.S.
        • Volkow N.D.
        • Wang G.J.
        • Ding Y.S.
        • Alexoff D.L.
        Distribution volume ratios without blood sampling from graphical analysis of PET data.
        J Cereb Blood Flow Metab. 1996; 16: 834-840
        • Lotrich F.E.
        • Pollock B.G.
        Meta-analysis of serotonin transporter polymorphisms and affective disorders.
        Psychiatr Genet. 2004; 14: 121-129
        • Mann J.J.
        • Huang Y.Y.
        • Underwood M.D.
        • Kassir S.A.
        • Oppenheim S.
        • Kelly T.M.
        • et al.
        A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide.
        Arch Gen Psychiatry. 2000; 57: 729-738
        • Mayberg H.S.
        • Brannan S.K.
        • Mahurin R.K.
        • Jerabek P.A.
        • Brickman J.S.
        • Tekell J.L.
        • et al.
        Cingulate function in depression: A potential predictor for treatment response.
        Neuroreport. 1997; 8: 1057-1061
        • Meyer J.H.
        • Houle S.
        • Sagrati S.
        • Carella A.
        • Hussey D.F.
        • Ginovart N.
        • et al.
        Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: Effects of major depressive episodes and severity of dysfunctional attitudes.
        Arch Gen Psychiatry. 2004; 61: 1271-1279
        • Meyer J.H.
        • Wilson A.A.
        • Ginovart N.
        • Goulding V.
        • Hussey D.
        • Hood K.
        • et al.
        Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: An [11C] DASB PET imaging study.
        Am J Psychiatry. 2001; 158: 1843-1849
        • Meyer J.H.
        • Wilson A.A.
        • Sagrati S.
        • Hussey D.
        • Carella A.
        • Potter W.Z.
        • et al.
        Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: An [11C] DASB positron emission tomography study.
        Am J Psychiatry. 2004; 161: 826-835
        • Mintun M.A.
        • Raichle M.E.
        • Kilbourn M.R.
        • Wooten G.F.
        • Welch M.J.
        A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.
        Ann Neurol. 1984; 15: 217-227
        • Nakamura M.
        • Ueno S.
        • Sano A.
        • Tanabe H.
        The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants.
        Mol Psychiatry. 2000; 5: 32-38
        • Neumeister A.
        • Hu X.
        • Luckenbaugh D.A.
        • Schwarz M.
        • Nugent A.C.
        • Bonne O.
        Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and healthy controls.
        Arch Gen Psychiatry. 2006; 63: 978-986
        • Neumeister A.
        • Young T.
        • Stastny J.
        Implications of genetic research on the role of the serotonin in depression: Emphasis on the serotonin type 1A receptor and the serotonin transporter.
        Psychopharmacology (Berl). 2004; 174: 512-524
        • Ni X.
        • Chan K.
        • Bulgin N.
        • Sicard T.
        • Bismil R.
        • McMain S.
        • et al.
        Association between serotonin transporter gene and borderline personality disorder.
        J Psychiatr Res. 2006; 40: 448-453
        • Owens M.J.
        • Nemeroff C.B.
        Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter.
        Clin Chem. 1994; 40: 288-295
        • Parsey R.V.
        • Hastings R.S.
        • Oquendo M.A.
        • Hu X.
        • Goldman D.
        • Huang Y.Y.
        • et al.
        Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of the serotonin transporter in the human brain.
        Am J Psychiatry. 2006; 163: 48-51
        • Praschak-Rieder N.
        • Wilson A.A.
        • Hussey D.
        • Carella A.
        • Wei C.
        • Ginovart N.
        • et al.
        Effects of tryptophan depletion on the serotonin transporter in healthy humans.
        Biol Psychiatry. 2005; 58: 825-830
        • Rabiner E.A.
        • Gunn R.N.
        • Castro M.E.
        • Sargent P.A.
        • Cowen P.J.
        • Koepp M.J.
        • et al.
        β-Blocker binding to human 5-HT1A receptors in vivo and in vitro: Implications for antidepressant therapy.
        Neuropsychopharmacology. 2000; 23: 285-293
        • Schloss P.
        • Henn F.A.
        New insights into the mechanisms of antidepressant therapy.
        Pharmacol Ther. 2004; 102: 47-60
        • Shioe K.
        • Ichimaya T.
        • Suhara T.
        • Takano A.
        • Sudo Y.
        • Yasuno F.
        • et al.
        No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.
        Synapse. 2003; 48: 184-188
        • Wendland J.R.
        • Martin B.J.
        • Kruse M.R.
        • Lesch K.P.
        • Murphy D.L.
        Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531.
        Mol Psychiatry. 2006; 11: 224-226
        • Willeit M.
        • Praschak-Rieder N.
        • Neumeister A.
        • Zill P.
        • Leisch F.
        • Stastny J.
        • et al.
        A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder.
        Mol Psychiatry. 2003; 8: 942-946
        • Willeit M.
        • Stastny J.
        • Pirker W.
        • Praschak-Rieder N.
        • Neumeister A.
        • Asenbaum S.
        • et al.
        No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism.
        Biol Psychiatry. 2001; 50: 8-12
        • Willeit M.
        • Praschak-Rieder N.
        • Neumeister A.
        • Pirker W.
        • Asenbaum S.
        • Vitouch O.
        • et al.
        [123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.
        Biol Psychiatry. 2000; 47: 482-489
        • Wilson A.A.
        • Ginovart N.
        • Hussey D.
        • Meyer J.H.
        • Houle S.
        In vitro and in vivo characterization of [11C]-DASB: A probe for in vivo measurements of the serotonin transporter by positron emission tomography.
        Nucl Med Biol. 2002; 29: 509-515
        • Wilson A.A.
        • Ginovart N.
        • Schmidt M.
        • Meyer J.H.
        • Threlkeld P.G.
        • Houle S.
        Novel radiotracers for imaging the serotonin transporter by positron emission tomography: Synthesis, radiosynthesis, and in vitro and ex vivo evaluation of 11C-labeled 2-(phenylthio)araalkylamines.
        J Med Chem. 2000; 43: 3103-3110
        • Yates M.
        • Leake A.
        • Candy J.M.
        • Fairbairn A.F.
        • McKeith I.G.
        • Ferrier I.N.
        5HT2 receptor changes in major depression.
        Biol Psychiatry. 1990; 27: 489-496
        • Yonan A.L.
        • Palmer A.A.
        • Gilliam T.C.
        Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism.
        Psychiatr Genet. 2006; 6: 31-34